ReviewBreast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: A systematic review
Introduction
The most likely source of metastatic lymphadenopathy in the axilla is the ipsilateral breast.1, 2, 3, 4 In 0.3–1.0% of all women with breast cancer metastatic lymphadenopathy is the first presenting symptom.5, 6, 7 Consequently when no other primary source becomes evident during workup or physical examination, and mammography or ultrasound of the breast shows no abnormalities, this is called occult breast cancer.
With the introduction of more advanced diagnostic techniques in the past century, like mammography and ultrasound of the breast, the incidence of occult breast cancer has decreased.8 In recent years other diagnostic modalities, like CT, positron emission tomography (PET) and other types of scintigraphy have also been used to find the primary source, but none of these techniques are applied routinely and evidence for routine use in occult breast cancer is insufficient.9, 10, 11, 12, 13, 14
Nowadays MRI of the breast is frequently applied when other diagnostic modalities fail to find a primary source in the breast. Although the sensitivity of MRI for detection of breast cancer is high, the specificity is much lower.15 Hence the correlation of detected MRI lesions to findings at pathology and the implications for treatment are important issues. Because of the low incidence of occult breast cancer, published studies usually consist of small numbers of patients which prevents addressing these matters adequately.
The goal of this systematic review is to give an overview of the value and additional considerations of using breast MRI in occult breast cancer. The questions that will be addressed are the following:
- 1.
What is the sensitivity and specificity of a breast MRI in case of an occult breast cancer?
- 2.
Is MRI guided biopsy preferred over MRI guided sonographic biopsy?
- 3.
Are the breast MRI findings correlated to the pathological findings?
- 4.
What percentage of patients with occult breast cancer and MRI detected lesions can be treated by breast conserving surgery?
Section snippets
Search strategy
In this systematic review the database of Pubmed, Embase, CINAHL and the Cochrane library were searched for patient studies (≤2009) using the MeSH terms: “axilla”, “neoplasms”, “unknown primary”, “breast neoplasms” and “magnetic resonance imaging” and using the free terms: “breast”, “cancer” or “carcinoma”, “occult”, “unknown primary”, “axilla” and “MRI”. Limits were set for languages; only English, German, Spanish, French and Dutch articles were included. Cross-references were used to find
Inclusion of studies
A total of 21 studies were selected that seemed relevant on screening of the abstract. On reading the full text articles another 6 studies were excluded because not all included patients fulfilled the definition of occult breast cancer. The remaining 15 studies were all retrospective studies, no prospective studies or randomized controlled trials were found and no male patients with occult breast cancer were described in these studies. A further 4 studies were excluded because it were case
Sensitivity and specificity of breast MRI
Breast MRI is often the first choice in attempting to find the breast primary in occult breast cancer. As a result, in approximately two thirds of the population the primary tumour can be detected.21, 23, 24, 25, 26, 27, 28 In line with studies on breast MRI for other indications, sensitivity for detection of occult breast cancer is high, but specificity is much lower.15, 25, 28 Thus, every lesion detected by MRI should be histologically confirmed either by MRI guided biopsy or by MRI guided
Conclusion
Occult breast cancer incidence is decreasing, because more primary breast cancers can be detected with the introduction of more advanced techniques. However, this clinical problem is still encountered regularly. Breast MRI can identify the primary tumour in approximately two thirds of this population, but because of the low specificity lesions need to be histologically confirmed. This can be achieved either by MRI or ultrasound, as long as all MRI detected lesions are histologically checked.
Authors' contributions
KH and FE conceived and designed the study. JB and BV were responsible for the data search and critical appraisal. JB produced the tables and wrote the manuscript. All other authors contributed to writing of the manuscript and approved the final version.
Conflicts of interest
The authors declare no conflicts of interest.
References (30)
- et al.
Prognosis of occult carcinoma of the breast
Am J Surg
(1963) - et al.
Detection of primary breast cancer presenting as metastatic carcinoma of unknown primary origin by 111In-pentetreotide scan
Ann Oncol
(1998) - et al.
A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer
Eur J Cancer
(2007) - et al.
Outcome after treatment of patients with mammographically occult, magnetic resonance imaging-detected breast cancer presenting with axillary lymphadenopathy
Clin Breast Cancer
(2004) - et al.
CT-guided preoperative needle localization of MRI-detected breast lesions
Eur J Radiol
(2001) - et al.
Breast cancer presenting as an axillary mass
Ann Surg
(1976) - et al.
Surgical significance of isolated axillary adenopathy
Ann Surg
(1957) - et al.
Axillary metastases from an unknown primary source
Isr J Med Sci
(1976) - et al.
Axillary lymph node metastasis from an occult breast cancer
Cancer
(1981) Management of occult breast cancer presenting as an axillary metastasis
Semin Surg Oncol
(1991)